Veradigm announces strategic investment in Singapore-based health tech startup Holmusk

US-based Veradigm has announced an investment in Holmusk, a global behavioural health real-world evidence and data analytics company in Singapore, as part of Holmusk’s $45 million series B financing round. The round was led by Veradigm, with participation …